CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
On January 29, 2021, our sponsor paid an aggregate of $25,000, or approximately $0.0025 per share, in exchange for the issuance of 5,000,000 Class B founder shares, par value $0.0001, and 5,000,000 Class K founder shares, par value $0.0001.
The Class B founder shares held by our initial stockholders will represent 15% of our outstanding shares of common stock immediately following the completion of this offering (excluding the Class K common stock, the private placement shares, forward-purchase shares and assuming our initial stockholders do not purchase any public shares in this offering), with the potential to own as a result of their Class B founder shares and Class K founder shares in the aggregate up to 30% of the outstanding shares of common stock upon completion of this offering (excluding the private placement shares, forward-purchase shares and assuming our initial stockholders do not purchase any public shares in this offering) based on certain triggering events.
The founder shares (including the shares of our Class A common stock issuable upon exercise thereof) may not, subject to certain limited exceptions, be transferred, assigned or sold by the holder. Prior to the completion of this offering, our sponsor transferred a certain amount of Class B founder shares to each of our independent directors at their original purchase price.
Our sponsor has agreed to purchase an aggregate of up to 1,000,000 shares of Class A common stock (the “forward-purchase shares”) for $10.00 per share, or an aggregate maximum amount of $10,000,000, in a private placement that will close simultaneously with the closing of our initial business combination. The forward-purchase shares will be identical to the public shares being sold in this offering, except the forward-purchase shares will be subject to transfer restrictions and certain registration rights, as described herein.
Our sponsor has committed, pursuant to a written agreement, to purchase an aggregate of 1,300,000 private placement shares (or 1,450,000 private placement shares if the over-allotment option is exercised in full) for a purchase price of $10.00 per share in a private placement that will occur simultaneously with the closing of this offering. As such, our sponsor’s interest in this transaction is valued at between $13,000,000 and $14,500,000, depending on the number of private placement shares purchased. The private placement shares may not, subject to certain limited exceptions, be transferred, assigned or sold by the holder.
As more fully discussed in the section of this prospectus entitled “Management — Conflicts of Interest,” if any of our officers or directors becomes aware of a business combination opportunity that falls within the line of business of any entity to which he or she has then-current fiduciary or contractual obligations, he or she will honor his or her fiduciary or contractual obligations to present such opportunity to such entity. Our officers and directors currently have certain relevant fiduciary duties or contractual obligations that may take priority over their duties to us.
Other than equity provided to our independent directors, no compensation of any kind, including finder’s and consulting fees, will be paid to our sponsor, officers and directors, or any of their respective affiliates, for services rendered prior to or in connection with the completion of an initial business combination. However, these individuals will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. Our audit committee will review on a quarterly basis all payments that were made to our sponsor, officers, directors or our or their respective affiliates and will determine which expenses and the amount of expenses that will be reimbursed. There is no cap or ceiling on the reimbursement of out-of-pocket expenses incurred by such persons in connection with activities on our behalf.
Our sponsor has agreed to loan us up to $300,000 to be used for a portion of the expenses of this offering. As of February 1, 2021, we have not borrowed any amount under the promissory note with our sponsor. This loan is non-interest bearing, unsecured and are due at the earlier of December 31, 2021 or the closing of this offering. The
136